Abstract Introduction: The Public Health Agency of Canada developed the Chronic Disease
Indicator Framework (the Framework) with the goal of systematizing and enhancing chronic …

• Seizures serotonin, although mild serotoninergic symptoms may be encountered among
patients receiving therapeutic doses of a single SSRI. This toxicity syndrome is uncommon …

Since the last publication of the recommendations for the management and treatment of
dyslipidemia, new clinical trial data have emerged that support a more vigorous approach to …

Background: Statins are prescribed to treat dyslipidemia (abnormal amount of lipids such as
cholesterol and/or fat in the blood) and reduce cardiovascular disease (CVD) risk. This study …

Background Regular statin use is an important tool in chronic disease management,
lowering cholesterol levels and reducing risk of cardiovascular disease (CVD). The …

Background While health service use appears to be positively correlated with resource
availability, no study has explored the interactions among health service supply …

Peer-reviewed, evidence-based recommendations for statin use in primary prevention of
cardiovascular events are limited. A narrative review of published randomized controlled …

Objective: The purpose of this research was to measure prevalent and incident statin use in
the population of British Columbia from 1996 to 2004 across specific patient characteristics …

Josephine Ho and associates1 report an unfortunate case of a 6-year-old girl with diabetic
ketoacidosis (DKA) and thromboembolic stroke. Although the authors do a credible job of …

The assessment by Douglas Manuel and associates1 of the 2003 Canadian dyslipidemia
guidelines2 is welcome, but they overlooked the all-cause mortality issue, where statins …